These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29915014)

  • 1. Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses.
    Grassi G; Pisano A; Bolignano D; Seravalle G; D'Arrigo G; Quarti-Trevano F; Mallamaci F; Zoccali C; Mancia G
    Hypertension; 2018 Aug; 72(2):483-491. PubMed ID: 29915014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic neural mechanisms in white-coat hypertension.
    Smith PA; Graham LN; Mackintosh AF; Stoker JB; Mary DA
    J Am Coll Cardiol; 2002 Jul; 40(1):126-32. PubMed ID: 12103266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic Neural Overdrive in the Obese and Overweight State.
    Grassi G; Biffi A; Seravalle G; Trevano FQ; Dell'Oro R; Corrao G; Mancia G
    Hypertension; 2019 Aug; 74(2):349-358. PubMed ID: 31203727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of single vasoconstrictor nerve units in hypertension.
    Mary DA; Stoker JB
    Acta Physiol Scand; 2003 Mar; 177(3):367-76. PubMed ID: 12609008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between central sympathetic activity and stages of human hypertension.
    Smith PA; Graham LN; Mackintosh AF; Stoker JB; Mary DA
    Am J Hypertens; 2004 Mar; 17(3):217-22. PubMed ID: 15001194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.
    Grassi G; D'Arrigo G; Pisano A; Bolignano D; Mallamaci F; Dell'Oro R; Quarti-Trevano F; Seravalle G; Mancia G; Zoccali C
    J Hypertens; 2019 Sep; 37(9):1746-1756. PubMed ID: 30950979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states.
    Seravalle G; Lonati L; Buzzi S; Cairo M; Quarti Trevano F; Dell'Oro R; Facchetti R; Mancia G; Grassi G
    J Hypertens; 2015 Jul; 33(7):1411-7. PubMed ID: 25827432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men.
    Hogarth AJ; Burns J; Mackintosh AF; Mary DA
    J Hum Hypertens; 2008 Aug; 22(8):544-9. PubMed ID: 18463670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.
    Grassi G; Seravalle G; Dell'Oro R; Arenare F; Facchetti R; Mancia G
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):469-75. PubMed ID: 19157817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension.
    Schobel HP; Heusser K; Schmieder RE; Veelken R; Fischer T; Luft FC
    J Am Soc Nephrol; 1998 Sep; 9(9):1581-7. PubMed ID: 9727365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.
    Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G
    Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Facchetti R; Mancia G
    Hypertension; 2020 Aug; 76(2):577-582. PubMed ID: 32594806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-unit sympathetic discharge : quantitative assessment in human hypertensive disease.
    Greenwood JP; Stoker JB; Mary DA
    Circulation; 1999 Sep; 100(12):1305-10. PubMed ID: 10491375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive.
    Greenwood JP; Scott EM; Stoker JB; Mary DA
    J Am Coll Cardiol; 2001 Nov; 38(6):1711-7. PubMed ID: 11704385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension.
    Huggett RJ; Burns J; Mackintosh AF; Mary DA
    Hypertension; 2004 Dec; 44(6):847-52. PubMed ID: 15520303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent muscle sympathetic responses to dynamic leg exercise in heart failure and age-matched healthy subjects.
    Notarius CF; Millar PJ; Murai H; Morris BL; Marzolini S; Oh P; Floras JS
    J Physiol; 2015 Feb; 593(3):715-22. PubMed ID: 25398528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.
    Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G
    Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload.
    Seravalle G; Dell'Oro R; Quarti-Trevano F; Spaziani D; Bertoli S; Airoldi F; Mancia G; Grassi G
    Hypertension; 2020 Nov; 76(5):1444-1450. PubMed ID: 32981363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.